Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats

Psychopharmacology

Volumn 222, Issue 2, 2012, Pages 269-276

  Johnson, Joshua E ^a   Slade, Susan ^a   Wells, Corinne ^a   Petro, Ann ^a   Sexton, Hannah ^a   Rezvani, Amir H ^a   Brown, Milton L ^b   Paige, Mikell A ^b   McDowell, Brian E ^b   Xiao, Yingxian ^b   Kellar, Kenneth J ^b   Levin, Edward D ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic; Nicotine; Sazetidine A; Selfadministration; Sex differences

Indexed keywords

NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR ALPHA4BETA2; SAZETIDINE A; UNCLASSIFIED DRUG;

ABSTINENCE; ANIMAL EXPERIMENT; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SELF ADMINISTRATION; FEMALE; MALE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SEX DIFFERENCE;

ANIMALS; AZETIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; NICOTINE; NICOTINIC AGONISTS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SELF ADMINISTRATION; SEX FACTORS; SMOKING CESSATION;

EID: 84864466131     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2642-z     Document Type: Article

References (17)

1. Chaudhri N, Caggiula AR, Donny EC, Booth S, Gharib MA, Craven LA, Allen SS, Sved AF, Perkins KA (2005) Sex differences in the contribution of nicotine and nonpharmacological stimuli to nicotine self-administration in rats. Psychopharmacol (Berl) 180:258-266
2. Donny EC, Caggiula AR, Rowell PP, Gharib MA, Maldovan V, Booth S, Mielke MM, Hoffman A, McCallum S (2000) Nicotine selfadministration in rats: Estrous cycle effects, sex differences and nicotinic receptor binding. Psychopharmacol (Berl) 151:392-405
3. Fiore MC, Smith SS, Jorenby DE, Baker TB (1994) The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA 271:1940-1947
4. Freedman R (2007) Exacerbation of schizophrenia by varenicline. Am J Psychiatry 164:1269
5. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR (2006) Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. JAMA 296:56-63
6. Katz B, Thesleff S (1957) A study of the desensitization produced by acetylcholine at the motor end-plate. J Physiol 138:63-80
7. Levin ED, Westman EC, Stein RM, Carnahan E, Sanchez M, Herman S, Behm FM, Rose JE (1994) Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking. J Clin Psychopharmacol 14:41-49
8. Levin ED, Rezvani AH, Xiao Y, Slade S, Cauley M,Wells C, Hampton D, Petro A, Rose JE, Brown ML, Paige MA, McDowell BE, Kellar KJ (2010) Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats. J Pharmacol Exp Ther 332:933-939
9. Lynch WJ (2009) Sex and ovarian hormones influence vulnerability and motivation for nicotine during adolescence in rats. Pharmacol Biochem Behav 94:43-50
10. McKee SA, Harrison EL, O'Malley SS, Krishnan-Sarin S, Shi J, Tetrault JM, Picciotto MR, Petrakis IL, Estevez N, Balchunas E (2009) Varenicline reduces alcohol self-administration in heavydrinking smokers. Biol Psychiatry 66:185-190
11. Morstad AE, Kutscher EC, Kennedy WK, Carnahan RM(2008) Hypomania with agitation associated with varenicline use in bipolar II disorder. Ann Pharmacother 42:288-289
12. Quick MW, Lester RA (2002) Desensitization of neuronal nicotinic receptors. J Neurobiol 53:457-478
13. Rezvani AH, Eddins D, Slade S, Hampton DS, Christopher NC, Petro A, Horton K, Johnson M, Levin ED (2008) Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: Persisting effects on locomotor activity, learning and nicotine selfadministration. Neuroscience 154:885-897
14. Rezvani AH, Slade S, Wells C, Petro A, Lumeng L, Li TK, Xiao Y, Brown ML, Paige MA, McDowell BE, Rose JE, Kellar KJ, Levin ED (2010) Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats. Psychopharmacol (Berl) 211:161-174
15. Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD 3rd, Williams KE (2007) Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52:985-994
16. Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE (2007) Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci USA 104:12518-12523
17. Xiao Y, Fan H, Musachio JL,Wei ZL, Chellappan SK, Kozikowski AP, Kellar KJ (2006) Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them. Mol Pharmacol 70:1454-1460